Geulah Livshits
Stock Analyst at Chardan Capital
(1.95)
# 3,008
Out of 4,865 analysts
198
Total ratings
30.61%
Success rate
-6.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Geulah Livshits
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNTI Senti Biosciences | Maintains: Buy | $12 | $2.78 | +331.65% | 9 | Jun 12, 2025 | |
| TSHA Taysha Gene Therapies | Maintains: Buy | $7 → $9 | $2.55 | +252.94% | 13 | May 29, 2025 | |
| RCKT Rocket Pharmaceuticals | Maintains: Buy | $46 → $17 | $2.72 | +525.00% | 18 | May 28, 2025 | |
| PRME Prime Medicine | Maintains: Buy | $16 → $12 | $1.62 | +643.03% | 5 | May 19, 2025 | |
| SLDB Solid Biosciences | Maintains: Buy | $16 → $15 | $4.61 | +225.38% | 7 | May 19, 2025 | |
| IPSC Century Therapeutics | Maintains: Buy | $7 → $6 | $0.59 | +914.88% | 6 | May 16, 2025 | |
| MGX Metagenomi | Maintains: Buy | $13 → $12 | $1.46 | +721.92% | 6 | May 15, 2025 | |
| LXEO Lexeo Therapeutics | Maintains: Buy | $22 → $20 | $3.92 | +410.20% | 9 | May 13, 2025 | |
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $28 → $25 | $4.15 | +502.41% | 9 | May 9, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $30 → $25 | $2.02 | +1,137.62% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $68 | $9.58 | +609.81% | 14 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 | $0.57 | +1,467.94% | 11 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 | $130.02 | +68.44% | 10 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $82 | $43.19 | +89.86% | 13 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 | $1.82 | +614.29% | 11 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $21.79 | +129.46% | 1 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $6 | $0.38 | +1,476.87% | 4 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.38 | - | 3 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.14 | - | 10 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $41 | $6.33 | +547.71% | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $5.88 | +325.17% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $1.87 | +543.43% | 4 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $191 → $208 | $25.55 | +714.09% | 7 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $1.62 | +887.65% | 4 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $90 | $8.66 | +939.26% | 1 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5.5 → $4 | $3.12 | +28.21% | 3 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $30 | $2.32 | +1,193.10% | 1 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $8.95 | +101.12% | 1 | Oct 27, 2020 |
Senti Biosciences
Jun 12, 2025
Maintains: Buy
Price Target: $12
Current: $2.78
Upside: +331.65%
Taysha Gene Therapies
May 29, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $2.55
Upside: +252.94%
Rocket Pharmaceuticals
May 28, 2025
Maintains: Buy
Price Target: $46 → $17
Current: $2.72
Upside: +525.00%
Prime Medicine
May 19, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $1.62
Upside: +643.03%
Solid Biosciences
May 19, 2025
Maintains: Buy
Price Target: $16 → $15
Current: $4.61
Upside: +225.38%
Century Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $7 → $6
Current: $0.59
Upside: +914.88%
Metagenomi
May 15, 2025
Maintains: Buy
Price Target: $13 → $12
Current: $1.46
Upside: +721.92%
Lexeo Therapeutics
May 13, 2025
Maintains: Buy
Price Target: $22 → $20
Current: $3.92
Upside: +410.20%
4D Molecular Therapeutics
May 9, 2025
Maintains: Buy
Price Target: $28 → $25
Current: $4.15
Upside: +502.41%
Iovance Biotherapeutics
May 9, 2025
Maintains: Buy
Price Target: $30 → $25
Current: $2.02
Upside: +1,137.62%
May 9, 2025
Maintains: Buy
Price Target: $68
Current: $9.58
Upside: +609.81%
May 9, 2025
Maintains: Buy
Price Target: $9
Current: $0.57
Upside: +1,467.94%
May 7, 2025
Maintains: Buy
Price Target: $219
Current: $130.02
Upside: +68.44%
May 7, 2025
Maintains: Buy
Price Target: $84 → $82
Current: $43.19
Upside: +89.86%
May 6, 2025
Maintains: Buy
Price Target: $13
Current: $1.82
Upside: +614.29%
Apr 9, 2025
Initiates: Buy
Price Target: $50
Current: $21.79
Upside: +129.46%
Mar 4, 2025
Maintains: Buy
Price Target: $7 → $6
Current: $0.38
Upside: +1,476.87%
Jan 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.38
Upside: -
Dec 13, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.14
Upside: -
Aug 11, 2023
Reiterates: Buy
Price Target: $41
Current: $6.33
Upside: +547.71%
Mar 23, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $5.88
Upside: +325.17%
Mar 22, 2023
Reiterates: Buy
Price Target: $12
Current: $1.87
Upside: +543.43%
Jan 18, 2023
Maintains: Neutral
Price Target: $191 → $208
Current: $25.55
Upside: +714.09%
Nov 15, 2022
Maintains: Buy
Price Target: $15 → $16
Current: $1.62
Upside: +887.65%
Nov 3, 2021
Maintains: Buy
Price Target: $100 → $90
Current: $8.66
Upside: +939.26%
Nov 3, 2021
Maintains: Neutral
Price Target: $5.5 → $4
Current: $3.12
Upside: +28.21%
Jul 23, 2021
Maintains: Neutral
Price Target: $50 → $30
Current: $2.32
Upside: +1,193.10%
Oct 27, 2020
Initiates: Buy
Price Target: $18
Current: $8.95
Upside: +101.12%